Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2010

Chen Kuan-Yu, Chen Jen-Hau, Shih Jin-Yuan, Yang Chih-Hsin, Yu Chong-Jen, Yang Pan-Chyr

Abstract excerpt

INTRODUCTION: Lung cancer has become a disease of elderly. However, there are limited data describing the specific therapies, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), for octogenarians with advanced non-small cell lung cancer (NSCLC). This study is to characterize the treatment modalities and outcomes for octogenarians with advanced NSCLC and to investigate the impact of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Large Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Quinazolines

Share to Radiotherapy Dosage

Share to Survival Rate

Source

Identifiers

PMID: 19884854
DOI: 10.1097/JTO.0b013e3181c09b28

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.PMID 19884854Read ↗

Treatment outcomes in elderly with advanced-stage non-small cell lung cancer.Semantic proximity Read ↗

Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer.Semantic proximity Read ↗

Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.Semantic proximity Read ↗

Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients.Semantic proximity Read ↗

Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.Semantic proximity Read ↗

Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer.Semantic proximity Read ↗

Short-and long-term outcomes of video-assisted thoracoscopic lobectomy in elderly patients with non-small-cell lung cancerSemantic proximity Read ↗

First-line treatment and overall survival in EGFR mutation-positive advanced non-small cell lung cancer: a national cohort study.Semantic proximity Read ↗

Survival analysis of patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi-center retrospective study.Semantic proximity Read ↗

Efficacy and safety of adjuvant EGFR-TKIs for non-small cell lung cancer with EGFR mutations after surgery: an updated meta-analysisSemantic proximity Read ↗

Treatment Pattern and Overall Survival of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicentric Real-World Study in China (CTONG1506)Semantic proximity Read ↗

Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.